🇺🇸 FDA
Patent

US 10980861

Glucokinase activator compositions for the treatment of diabetes

granted A61KA61K31/426A61K31/4985

Quick answer

US patent 10980861 (Glucokinase activator compositions for the treatment of diabetes) held by VTV THERAPEUTICS LLC expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/426, A61K31/4985, A61K38/22, A61K38/26